# Red Blood Cell Transfusion in ECMO - A Feasibility Trial

> **NCT05814094** · NA · RECRUITING · sponsor: **Australian and New Zealand Intensive Care Research Centre** · enrollment: 120 (estimated)

## Conditions studied

- Blood Loss Anemia
- Extracorporeal Membrane Oxygenation Complication
- Disability Physical
- Cognitive Ability, General
- Functional Status

## Interventions

- **OTHER:** Red Blood Cell Transfusion
- **OTHER:** Red Blood Cell Transfusion

## Key facts

- **NCT ID:** NCT05814094
- **Lead sponsor:** Australian and New Zealand Intensive Care Research Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-20
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05814094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05814094, "Red Blood Cell Transfusion in ECMO - A Feasibility Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05814094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*